Table 1 Physician and patient characteristics by country
Characteristic | France | Germany | Italy | Spain | UK | Total |
|---|---|---|---|---|---|---|
Physicians | 75 | 75 | 72 | 75 | 51 | 348 |
Urologists | 41 | 41 | 38 | 41 | 30 | 191 |
Oncologists | 34 | 34 | 34 | 34 | 21 | 157 |
Patient sample size | 750 | 782 | 720 | 750 | 475 | 3477 |
Proportion with CRPC | 330 (44) | 347 (44) | 294 (41) | 288 (38) | 146 (31) | 1405 (40) |
Proportion with mCRPC | 272 (36) | 296 (38) | 218 (30) | 221 (29) | 112 (24) | 1119 (32) |
% of CRPC patients | 82 | 85 | 74 | 77 | 77 | 80 |
Disease status | ||||||
Localised | 170 (23) | 172 (22) | 219 (30) | 171 (23) | 105 (22) | 837 (24) |
Locally advanced | 35 (5) | 60 (8) | 47 (7) | 41 (5) | 26 (5) | 209 (6) |
Metastatic | 419 (56) | 435 (56) | 302 (42) | 391 (52) | 228 (48) | 1775 (51) |
Unknown | 126 (17) | 115 (15) | 152 (21) | 147 (20) | 116 (24) | 656 (19) |
Comorbidities at baseline, mean (SD) | 1.8 (1.4) | 1.7 (1.4) | 1.8 (1.4) | 2.2 (1.4) | 1.7 (1.3) | 1.8 (1.5) |
Hypertension, n (%) | 777 (65.5) | 158 (59.9) | 214 (73.3) | 191 (70.2) | 138 (57.7) | 76 (64.4) |
Diabetes, n (%) | 376 (31.7) | 68 (25.8) | 103 (35.3) | 98 (36.0) | 72 (30.1) | 35 (29.7) |
Hyperlipidaemia, n (%) | 338 (28.5) | 87 (33.0) | 59 (20.2) | 82 (30.2) | 90 (37.7) | 20 (17.0) |